UpdatesPress Release
Jagsonpal Pharma acquires 85% of Aequitas Healthcare for Rs. 20.8 Cr, funded internally.
Jagsonpal Pharmaceuticals LimitedJAGSNPHARM · Filed with the exchange
This strategic move establishes Jagsonpal in the hospital segment, leveraging Aequitas's Rs. 53 Cr FY26 revenue for omnichannel expansion.
No comments yet. Be the first.